Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

All Monthly Communication Reports for Eli Lilly Canada Inc.

Kenneth L Custer, President and General Manager (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results null-null of 145

  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Shuvaloy Majumdar, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2024-09-24
    Posted date: 2024-10-15
    Communication number: 6034-616825 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2024-09-24
    Posted date: 2024-10-15
    Communication number: 6034-616818 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Helena Jaczek, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 6034-616817 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Yasir Naqvi, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2024-09-23
    Posted date: 2024-10-15
    Communication number: 6034-616814 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Arun Alexander, Deputy Head of Mission | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry
    Communication date: 2024-09-12
    Posted date: 2024-10-15
    Communication number: 6034-616828 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Judith Seidman, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2024-06-27
    Posted date: 2024-07-15
    Communication number: 6034-609625 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bobby Chauhan, Director | Health Canada (HC)
    • Daniel MacDonald, Director General, Drugs for Rare Diseases | Strategic Policy Branch | Health Canada (HC)
    • Michelle Boudreau, Executive Director | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2024-06-06
    Posted date: 2024-07-15
    Communication number: 6034-609621 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Paul Brogan, Market Director | Invest in Canada Hub
    • Harold Dremin, Chief Investor Services Officer | Invest in Canada Hub

    Subject Matter of the communication: Health, Industry
    Communication date: 2024-06-04
    Posted date: 2024-07-04
    Communication number: 6034-609623 (amended from 6034-609622) View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2024-06-02
    Posted date: 2024-07-15
    Communication number: 6034-609619 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Laura Stokes, Policy Analyst | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2024-05-24
    Posted date: 2024-06-15
    Communication number: 6034-606160 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jade Mallette, Director of Parliamentary Affairs | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2024-05-21
    Posted date: 2024-06-15
    Communication number: 6034-605252 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Connor MacDonald, Policy Advisor | House of Commons
    • Bryce McRae, Manager of Stakeholder Relations | Conservative - House Officers | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2024-05-21
    Posted date: 2024-06-15
    Communication number: 6034-605251 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health
    Communication date: 2024-04-22
    Posted date: 2024-05-15
    Communication number: 6034-603127 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Ciesielski, Manager, Office of Patented Medicines and Liaison | Health Canada (HC)
    • Anne Bowes, Director | Health Canada (HC)
    • David Lee, Chief Regulatory Officer | Health Canada (HC)
    • Erin Campbell, Director | Innovation, Science and Economic Development Canada (ISED)
    • Paul Brogan, Market Director | Invest in Canada Hub

    Subject Matter of the communication: Health
    Communication date: 2024-02-26
    Posted date: 2024-03-15
    Communication number: 6034-595827 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Loris Mirella, Director | Global Affairs Canada (GAC)
    • David Norris, Senior Trade Policy Officer | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health
    Communication date: 2024-01-31
    Posted date: 2024-02-15
    Communication number: 6034-592233 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Caroline Menard, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2024-01-23
    Posted date: 2024-02-15
    Communication number: 6034-592232 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health
    Communication date: 2024-01-23
    Posted date: 2024-02-15
    Communication number: 6034-592230 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2024-01-23
    Posted date: 2024-02-15
    Communication number: 6034-592192 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Paul Brogan, Market Director | Invest in Canada Hub
    • Abbigael Loomis , Investor Services Associate | Invest in Canada Hub

    Subject Matter of the communication: Economic Development
    Communication date: 2023-12-18
    Posted date: 2024-01-15
    Communication number: 6034-589882 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ophelia John, Senior Policy Advisor | Health Canada (HC)
    • Eshan Naik, Director of Policy | Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-12-14
    Posted date: 2024-01-15
    Communication number: 6034-589881 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-10-06
    Posted date: 2023-11-15
    Communication number: 6034-581797 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)
    • Greg Loyst, Director General | Health Canada (HC)
    • Linsey Hollett, Assistant Deputy Minister | Health Canada (HC)
    • Marie-Elisabeth Lebrun, Director | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-08-01
    Posted date: 2023-09-15
    Communication number: 6034-576324 (amended from 6034-576323) View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Melissa Lantsman, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-05-24
    Posted date: 2023-06-15
    Communication number: 6034-567899 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eric Belair , Associate Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)
    • Suzanne McGurn, President and CEO | CADTH | Health Canada (HC)
    • Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-03-09
    Posted date: 2023-04-15
    Communication number: 6034-562097 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ben Martin, Member's Assistant | House of Commons
    • Kyle Seeback , Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2022-12-05
    Posted date: 2023-01-16
    Communication number: 6034-553277 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
    • Kasondra White, Director | Innovation, Science and Economic Development Canada (ISED)
    • Samir Chhabra, Officer | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Departmental Liaison Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: International Trade
    Communication date: 2022-12-01
    Posted date: 2023-01-16
    Communication number: 6034-553276 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nicolas Lesieur, Senior Trade Policy Officer | Global Affairs Canada (GAC)
    • Clarissa Allen, Trade Policy Officer | Global Affairs Canada (GAC)
    • Loris Mirella, Director | Intellectual Property Trade | Global Affairs Canada (GAC)

    Subject Matter of the communication: International Trade
    Communication date: 2022-11-30
    Posted date: 2022-12-15
    Communication number: 6034-549927 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mary Ng, Minister of International Trade, Export Promotion, Small Business and Economic Development | Global Affairs Canada (GAC)

    Subject Matter of the communication: International Trade
    Communication date: 2022-11-23
    Posted date: 2022-12-15
    Communication number: 6034-549924 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health
    Communication date: 2022-10-27
    Posted date: 2022-11-15
    Communication number: 6034-546208 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2022-09-28
    Posted date: 2022-10-15
    Communication number: 6034-542866 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2022-08-25
    Posted date: 2022-09-15
    Communication number: 6034-541288 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2022-06-28
    Posted date: 2022-07-15
    Communication number: 6034-537379 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health
    Communication date: 2022-05-24
    Posted date: 2022-06-15
    Communication number: 6034-534272 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2022-05-19
    Posted date: 2022-06-15
    Communication number: 6034-534270 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director | Health Canada (HC)
    • Samir Khan, Director | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-05-16
    Posted date: 2022-06-15
    Communication number: 6034-534268 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health
    Communication date: 2022-04-07
    Posted date: 2022-05-16
    Communication number: 6034-531020 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Minister of Health, Minister's Office | Health Canada (HC)
    • Jean-Sebastien Bock, Director of Policy | Minister of Health, Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-04-04
    Posted date: 2022-05-16
    Communication number: 6034-531021 (amended from 6034-531018) View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2022-03-31
    Posted date: 2022-04-16
    Communication number: 6034-527904 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2022-03-29
    Posted date: 2022-04-16
    Communication number: 6034-527901 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director, | Strategy Policy Branch, Office of Pharmaceutical Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-03-29
    Posted date: 2022-04-16
    Communication number: 6034-527900 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2022-03-17
    Posted date: 2022-04-16
    Communication number: 6034-527866 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2022-01-27
    Posted date: 2022-02-15
    Communication number: 6034-521400 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dylan Marando, Senior Policy Advisor | Policy and Cabinet Affairs | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2021-08-03
    Posted date: 2021-09-15
    Communication number: 6034-513871 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Patrick Weiler, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2021-07-08
    Posted date: 2021-08-16
    Communication number: 6034-512444 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-06-15
    Posted date: 2021-07-15
    Communication number: 6034-510029 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-06-10
    Posted date: 2021-07-15
    Communication number: 6034-510028 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marcus Powlowski, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2021-05-27
    Posted date: 2021-06-15
    Communication number: 6034-506913 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jacqueline Arthur, Sr Manager, Policy Development, AMR Division | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
    • Bersabel Ephrem, Director General | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
    • Niyi Lawuyi, Advisor to Director General | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2021-02-01
    Posted date: 2021-03-15
    Communication number: 6034-497966 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Boyan Gerasimov, Director of Policy | Office of the Minister, Minister of Public Services and Procurement Canada | Public Services and Procurement Canada (PSPC)
    • Sheryl Groeneweg, Director General | Director's General Office, Manufacturing and Life Sciences Branch, Industry Sector | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2021-01-28
    Posted date: 2021-02-15
    Communication number: 6034-495107 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jacqueline Arthur, Sr Manager, Policy Development, AMR Division | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
    • Jennifer Siushansian, Public Health Advisor | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
    • Niyi Lawuyi, Advisor to Director General | Director General's Office - Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2020-12-16
    Posted date: 2021-02-11
    Communication number: 6034-495116 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Arianne Reza, Assistant Deputy Minister, Procurement | ADM - Procurement Branch, Acquisitions Program | Public Services and Procurement Canada (PSPC)
    • Roman Szumski, Senior Vice President | Sr VP's office, Vaccine Acquisition Branch | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2020-12-08
    Posted date: 2021-02-11
    Communication number: 6034-495112 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health
    Communication date: 2020-10-22
    Posted date: 2020-11-16
    Communication number: 6034-486812 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy at Office of the Minister of Health | Health Canada (HC)
    • Rick Theis, Director of Policy and Cabinet Affairs | Prime Minister's Office (PMO)
    • Bud Sambasivam, Senior Policy Advisor | Deputy Prime Minister and Minister of Intergovernmental Affairs | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2020-10-20
    Posted date: 2020-11-16
    Communication number: 6034-486679 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health
    Communication date: 2020-10-07
    Posted date: 2020-11-16
    Communication number: 6034-486680 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-09-17
    Posted date: 2020-10-09
    Communication number: 6034-483443 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Matthew Jeneroux, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2020-06-23
    Posted date: 2020-07-14
    Communication number: 6034-477639 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Doug Clark, Executive Director | PMPRB | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health
    Communication date: 2020-06-05
    Posted date: 2020-07-14
    Communication number: 6034-477638 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2020-05-15
    Posted date: 2020-06-15
    Communication number: 6034-475700 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
    • Supriya Sharma, Chief Medical Advisor, HC | Health Products and Food Branch | Health Canada (HC)
    • Celia Lourenco, Director General, Biologics and Genetic Therapies Directorate | Health Products and Food Branch | Health Canada (HC)
    • J Patrick Stewart, Director General, Therapeutic Products Directorate | Health Products and Food Branch | Great Lakes Pilotage Authority
    • Greg Loyst, Director General, Policy and Regulatory Strategies | Regulatory, Operations and Enforcement Branch | Health Canada (HC)
    • Gina Charos, Director General | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
    • Sheryl Groeneweg, Director General | Manufacturing and Life Sciences Branch, Industry Sector | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2020-04-16
    Posted date: 2020-05-14
    Communication number: 6034-472369 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Assistant Deputy Minister | Trade Policy and Negotiations | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Intellectual Property, Research and Development
    Communication date: 2020-03-06
    Posted date: 2020-04-15
    Communication number: 6034-471094 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-05-29
    Posted date: 2019-06-11
    Communication number: 6034-454844 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bill Blair, Minister of Border Security and Organized Crime Reduction | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-05-24
    Posted date: 2019-06-14
    Communication number: 6034-455781 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Kovacecvic, Assistant Deputy Minister | Federal-Provincial Relations and Social Policy Branch | Finance Canada (FIN)
    • Suzy Mccdonald, Associate Assistant Deputy Minister | Federal-Provincial Relations and Social Policy Branch | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-03-11
    Posted date: 2019-03-18
    Communication number: 6034-448302 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | PMPRB | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry, Research and Development
    Communication date: 2019-03-07
    Posted date: 2019-03-18
    Communication number: 6034-448304 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groeneweg, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology, Economic Development
    Communication date: 2019-01-16
    Posted date: 2019-01-28
    Communication number: 6034-444256 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bill Blair, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2018-12-17
    Posted date: 2019-01-15
    Communication number: 6034-443750 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Economic Development
    Communication date: 2018-12-04
    Posted date: 2019-01-13
    Communication number: 6034-443517 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Guy Foregeron, Assistant Secretary, Regulatory Affairs Sector | Treasury Board | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry, International Trade, Research and Development
    Communication date: 2018-11-14
    Posted date: 2018-11-19
    Communication number: 6034-439848 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-10-25
    Posted date: 2018-11-01
    Communication number: 6034-436876 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Daniel Albas, Opposition on Innovation, Science and Economic Developement Critic | House of Commons

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2018-10-23
    Posted date: 2018-11-09
    Communication number: 6034-437545 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gianluca Cairo, Chief of Staff to Minister Bains | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2018-10-23
    Posted date: 2018-11-09
    Communication number: 6034-437542 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • John Knubley, Deputy Minister, ISED | ISED | Innovation, Science and Economic Development Canada (ISED)
    • Mark Schaan, Director General, Market Framework Policy branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2018-10-23
    Posted date: 2018-11-09
    Communication number: 6034-437537 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Director General | Marketplace Framework, Policy Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2018-10-03
    Posted date: 2018-11-01
    Communication number: 6034-436875 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-09-11
    Posted date: 2018-09-28
    Communication number: 6034-434203 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | PMPRB | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-07-17
    Posted date: 2018-08-13
    Communication number: 6034-432191 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | PMPRB | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-27
    Posted date: 2018-08-13
    Communication number: 6034-432193 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor, Office of the Minister of Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development, Economic Development
    Communication date: 2018-06-11
    Posted date: 2018-06-14
    Communication number: 6034-428735 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Maximilien Roy, Policy Advisor Office of the Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Health, Research and Development, Economic Development
    Communication date: 2018-06-11
    Posted date: 2018-06-14
    Communication number: 6034-428726 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Policy Director | Health Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-06-11
    Posted date: 2018-06-14
    Communication number: 6034-428679 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicines Review Board | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Economic Development
    Communication date: 2018-05-17
    Posted date: 2018-08-13
    Communication number: 6034-428683 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-04-10
    Posted date: 2018-04-12
    Communication number: 6034-423574 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Abby Hoffman, Assistant Deputy Minister | Strategic Policy | Health Canada (HC)
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    • John Knubley, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Gianluca Cairo, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
    • David MacFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
    • Genevieve Hinse, Chief of Staff | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Health Canada (HC)
    • Hilary Travis, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-04-03
    Posted date: 2018-04-13
    Communication number: 6034-424116 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health
    Communication date: 2018-03-07
    Posted date: 2018-03-16
    Communication number: 6034-422586 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • kathryn Nowers, Senior Policy Advisor | Minister of Health's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2017-12-07
    Posted date: 2017-12-07
    Communication number: 6034-414866 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bill Blair, Parliamentry Secretary | Health | House of Commons

    Subject Matter of the communication: Health, Industry, Research and Development
    Communication date: 2017-12-07
    Posted date: 2017-12-07
    Communication number: 6034-414864 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)
    • Abby Hoffman, Assistant Deputy Minister | Health Canada (HC)
    • Kendal Weber, Associate Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Research and Development, Economic Development
    Communication date: 2017-11-14
    Posted date: 2017-12-13
    Communication number: 6034-415704 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sarah Hussaini, Policy | Prime Minister's office | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
    Communication date: 2017-11-01
    Posted date: 2017-11-03
    Communication number: 6034-411215 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David McFarlane, Director of Policy | ISED | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
    Communication date: 2017-11-01
    Posted date: 2017-11-03
    Communication number: 6034-411214 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry
    Communication date: 2017-10-10
    Posted date: 2017-10-23
    Communication number: 6034-410559 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Frank Baylis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2017-09-19
    Posted date: 2017-09-22
    Communication number: 6034-408338 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Corinne Guenette, Director, Life Science Industries, Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Economic Development
    Communication date: 2017-09-18
    Posted date: 2017-09-22
    Communication number: 6034-408339 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • douglas clark, Executive Director | Patented Medicines Pricing Review Board | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Economic Development
    Communication date: 2017-08-03
    Posted date: 2017-09-05
    Communication number: 6034-407323 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bill Blair, Member of Parliament, Scarborough Southwest | House of Commons | House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, Research and Development
    Communication date: 2017-07-11
    Posted date: 2017-08-11
    Communication number: 6034-406575 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kelly Gillis, Associate Deputy Minister | ISED | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development, Economic Development
    Communication date: 2017-06-20
    Posted date: 2017-07-18
    Communication number: 6034-405909 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Research and Development, Economic Development
    Communication date: 2017-05-23
    Posted date: 2017-05-23
    Communication number: 6034-401385 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Director General | Market Place Framework | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2017-01-30
    Posted date: 2017-02-08
    Communication number: 6034-393380 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Director General | Marketplace Framework Policy Branch, Strategic Policy Sector | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2016-11-17
    Posted date: 2016-11-29
    Communication number: 6034-389106 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Economic Development
    Communication date: 2016-10-11
    Posted date: 2016-11-14
    Communication number: 6034-387639 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ian Foucher, Policy Advisor | Office of the Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2016-06-10
    Posted date: 2016-07-15
    Communication number: 6034-381305 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Justin To, Policy Advisor | Office of the Prime Minister | Prime Minister's Office (PMO)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2016-06-10
    Posted date: 2016-07-15
    Communication number: 6034-381302 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dev Saxena, Policy Advisor | Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2016-06-10
    Posted date: 2016-07-15
    Communication number: 6034-381295 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • John Oliver, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Research and Development, Economic Development
    Communication date: 2016-05-10
    Posted date: 2016-05-24
    Communication number: 6034-377669 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Celina Caesar-Chavannes, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2016-05-10
    Posted date: 2016-05-24
    Communication number: 6034-377668 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2016-05-09
    Posted date: 2016-06-15
    Communication number: 6034-377670 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rachael Harder, Member of Parliament | House of Commons
    • Colin Carrie, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2016-05-03
    Posted date: 2016-05-03
    Communication number: 6034-375606 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brian Clow, Chief of Staff | Global Affairs Canada (GAC)
    • Sarah Husseini, Policy Advisor | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry, Intellectual Property, International Trade, Economic Development
    Communication date: 2016-04-13
    Posted date: 2016-04-15
    Communication number: 6034-374735 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Corinne Guenette, Director, Life Science Industries, Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, International Trade, Research and Development, Economic Development
    Communication date: 2016-04-13
    Posted date: 2016-04-15
    Communication number: 6034-374733 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Len Webber, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2016-04-12
    Posted date: 2016-05-03
    Communication number: 6034-374204 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marco Mendicino, MP | House of Commons

    Subject Matter of the communication: Intellectual Property, International Trade, Research and Development
    Communication date: 2016-04-07
    Posted date: 2016-04-15
    Communication number: 6034-374730 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marc Serre, MP | House of Commons

    Subject Matter of the communication: Intellectual Property, International Trade, Economic Development
    Communication date: 2016-03-22
    Posted date: 2016-04-15
    Communication number: 6034-374725 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Terry Beech, Parliamentary Secretary | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Intellectual Property, International Trade, Taxation and Finance, Research and Development
    Communication date: 2016-03-21
    Posted date: 2016-04-15
    Communication number: 6034-374722 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francois-Philippe Champagne, Parliamentary Secretary | Finance | Finance Canada (FIN)

    Subject Matter of the communication: Industry, Intellectual Property, Research and Development, Economic Development
    Communication date: 2016-03-07
    Posted date: 2016-03-11
    Communication number: 6034-371452 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Thomas Mulcair, Leader New Democratic Party | House of Commons

    Subject Matter of the communication: Intellectual Property, International Trade, Economic Development
    Communication date: 2016-02-23
    Posted date: 2016-03-11
    Communication number: 6034-371448 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rona Ambrose, Leader of the Opposition | Opposition | House of Commons

    Subject Matter of the communication: Industry, International Trade, Economic Development
    Communication date: 2016-02-23
    Posted date: 2016-03-11
    Communication number: 6034-371443 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Earl Dreeshan, Vice-Chair | Standing Committee on Industry, Science and Technology | House of Commons

    Subject Matter of the communication: Industry, Science and Technology, Research and Development, Economic Development
    Communication date: 2016-02-23
    Posted date: 2016-03-11
    Communication number: 6034-371440 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tracey Ramsey, Critic | International Trade | House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2016-02-23
    Posted date: 2016-03-11
    Communication number: 6034-371438 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Karen Vecchio, Critic | Families, Children and Social Development | House of Commons

    Subject Matter of the communication: Industry, International Trade, Economic Development
    Communication date: 2016-02-23
    Posted date: 2016-03-15
    Communication number: 6034-371435 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Terry Beech, Parliamentary Secretary | Science | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Research and Development, Economic Development
    Communication date: 2016-02-23
    Posted date: 2016-03-11
    Communication number: 6034-371431 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Claude Poissant, Parliamentary Secretary | Agriculture and Agri-Food | Agriculture and Agri-Food Canada (AAFC)

    Subject Matter of the communication: Industry, International Trade, Research and Development
    Communication date: 2016-02-23
    Posted date: 2016-03-11
    Communication number: 6034-371429 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sarah Hussaini, Policy Advisor | International Trade | Global Affairs Canada (GAC)
    • Simon Beauchemin, Special Assistant, Parliamentary Affairs | International Trade | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry, Intellectual Property, Research and Development
    Communication date: 2016-01-07
    Posted date: 2016-02-15
    Communication number: 6034-366601 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Deborah Levy, Chief of Staff | Office of the Minister of State (small business and tourism) | House of Commons

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2014-09-29
    Posted date: 2014-10-15
    Communication number: 6034-335847 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Cynthia Tran, Advisor, Stakeholder Relations and Outreach | PMO | Prime Minister's Office (PMO)
    • Virginie Bonneau, Regional Affairs Advisor, Quebec | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2014-09-29
    Posted date: 2014-10-15
    Communication number: 6034-335843 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Maxime Laliberte, Policy Advisor | Office of the Minister of the Economic Development Agency for Quebec | House of Commons

    Subject Matter of the communication: Industry, Science and Technology, Taxation and Finance
    Communication date: 2014-09-25
    Posted date: 2014-10-15
    Communication number: 6034-335835 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Virginie Bonneau, Regional Affairs Advisor | Quebec | Prime Minister's Office (PMO)

    Subject Matter of the communication: Industry
    Communication date: 2014-07-23
    Posted date: 2014-08-26
    Communication number: 6034-332329 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dan Brown, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2014-02-24
    Posted date: 2014-03-15
    Communication number: 6034-319372 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dan Harris, Memeber of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2014-02-18
    Posted date: 2014-03-16
    Communication number: 6034-319532 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eve Adams, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2014-01-09
    Posted date: 2014-02-15
    Communication number: 6034-316129 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Devinder Shory, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2013-12-04
    Posted date: 2014-02-15
    Communication number: 6034-316130 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Wilks, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2013-11-28
    Posted date: 2013-12-15
    Communication number: 6034-307911 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dany Morin, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2013-11-27
    Posted date: 2013-12-03
    Communication number: 6034-307910 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Art Eggleton, Senator | Senate of Canada

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2013-11-26
    Posted date: 2013-12-15
    Communication number: 6034-307912 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Chris Charlton, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2013-11-25
    Posted date: 2013-12-03
    Communication number: 6034-307909 (amended from 6034-307891) View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ron Cannan, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2013-11-18
    Posted date: 2013-12-03
    Communication number: 6034-307889 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dan Harris, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2013-10-10
    Posted date: 2013-12-03
    Communication number: 6034-307929 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gary Goodyear, Minister of State | Office of the Minister of State | Federal Economic Development Agency for Southern Ontario (FedDev)
    • Mark Schaan, Director, Pharmaceutical Policy | Life Science Industries Branch | Industry Canada
    • Thomas Coughlan, Policy Advisor | Office of the Minister of State | Federal Economic Development Agency for Southern Ontario (FedDev)

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology
    Communication date: 2013-04-23
    Posted date: 2013-05-31
    Communication number: 6034-275330 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gary Doer, Canada's Ambassador to the US | Canadian Trade Commission Service | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Intellectual Property, International Trade
    Communication date: 2013-03-05
    Posted date: 2013-05-31
    Communication number: 6034-275329 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dan Harris, Member of Parliament | Scarborough Southwest (Ontario) | House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2013-01-25
    Posted date: 2013-04-16
    Communication number: 6034-269836 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisory | Minister's Office | Industry Canada

    Subject Matter of the communication: Intellectual Property
    Communication date: 2012-10-29
    Posted date: 2012-11-15
    Communication number: 6034-245083 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rick Stewart, Secretary to the Cabinet | Liaison Secretariat for Macroeconomic Policy | Privy Council Office (PCO)
    • Sylvain Laporte, CEO, Commissioner of Patents | Canadian Intellectual Property Office | Industry Canada
    • Chris Evans, Chair, Patents Appeals Board | Canadian Intellectual Property Office | Industry Canada

    Subject Matter of the communication: Intellectual Property
    Communication date: 2012-10-16
    Posted date: 2012-11-15
    Communication number: 6034-245019 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andre Bachand, Senior Advisor | Prime Minister's Office | Prime Minister's Office (PMO)
    • Sean Speer, Senior Economic Policy Advisor | Prime Minister's Office | Prime Minister's Office (PMO)
    • Andrea van Vugt, Policy Advisor | Foreign Affairs, Trade & International Development | Prime Minister's Office (PMO)
    • Phil Harwood, Policy Advisor | Prime Minister's Office | Prime Minister's Office (PMO)
    • Stefan Stefanov, Intern | Prime Minister's Office | Prime Minister's Office (PMO)
    • Sean O'Leary, Policy Advisor | Ministry of Industry | Industry Canada

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2012-02-28
    Posted date: 2012-04-26
    Communication number: 6034-220327 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Karen Dodds, ADM | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2010-05-31
    Posted date: 2010-08-03
    Communication number: 6034-152959 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ron Parker, Senior ADM | Industry Sector | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2010-05-31
    Posted date: 2010-08-03
    Communication number: 6034-152958 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tony Clement, Minister of Industry | Industry Canada

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2010-05-04
    Posted date: 2010-08-03
    Communication number: 6034-152957 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Richard Discerni, Deputy Minister, Industry Canada | Industry Canada | Industry Canada

    Subject Matter of the communication: Intellectual Property, Science and Technology, Taxation and Finance
    Communication date: 2009-05-28
    Posted date: 2009-07-06
    Communication number: 6034-111876 View monthly communication report
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tony Clement, Industry Minister | Ministry of Industry | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance
    Communication date: 2009-05-18
    Posted date: 2009-07-06
    Communication number: 6034-111874 View monthly communication report
Date Modified: